0001640455-23-000053.txt : 20230406
0001640455-23-000053.hdr.sgml : 20230406
20230406163750
ACCESSION NUMBER: 0001640455-23-000053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230404
FILED AS OF DATE: 20230406
DATE AS OF CHANGE: 20230406
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MURRAY RICHARD /CA/
CENTRAL INDEX KEY: 0001242935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 23806692
MAIL ADDRESS:
STREET 1: 22643 WOODRIDGE CT
CITY: CUPERTINO
STATE: CA
ZIP: 95014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_168081345926690.xml
FORM 4
X0407
4
2023-04-04
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001242935
MURRAY RICHARD /CA/
C/O JOUNCE THERAPEUTICS, INC.
780 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
1
0
0
0
1
Common Stock
2023-04-04
4
S
0
39228
1.85
D
188779
D
Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The automatic sale instructions for the sell-to-cover were intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Securities Exchange Act of 1934, as amended, and to be interpreted to comply with the requirements of Rule 10b5-1(c), and these instructions were given on September 17, 2019.
/s/ Caroline G. Gammill, by power of attorney
2023-04-06